Robert Thomas Freeman, Chief Financial Officer at Alignment Healthcare, Inc. (ALHC), sold 152,122 shares at $12.00 ($1.7M) on 2024-09-13, disclosed to the SEC on 2024-09-13.
Scheduled sale ($1.7M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.01 | 8,561 | $86K | 5.1% |
| 2 | $10.01 | 8,561 | $86K | 5.1% |
| 3 | $11.00 | 120,500 | $1.3M | 79.3% |
| 4 | $12.00 | 14,500 | $174K | 10.4% |
| Total | $10.98 avg | 152,122 | $1.7M | 100% |
| Filing → |
| ALHC | SELL | 2025-03-13 | $450K | — | Filing → |
| ALHC | SELL | 2025-03-06 | $10.7M | — | Filing → |
| ALHC | SELL | 2024-11-13 | $409K | — | Filing → |